Dexamethasone for Inpatients With COVID-19 in a National Cohort.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2023.8516
Abstract: Importance Limited effective therapeutics are available to hospitalized patients with COVID-19. Clinical trials and observational studies have shown varying effects of systemic corticosteroids, including dexamethasone, in hospitalized patients with COVID-19, with limited descriptions of important… read more here.
Keywords: supplemental oxygen; discharge hospice; mortality discharge; cohort ... See more keywords